TranspariMED works to end evidence distortion in medicine.
Failure to register and fully report clinical trials harms patients, wastes taxpayers' money, and slows down the development of new treatments, vaccines and cures.
TranspariMED uses research-driven advocacy to develop and promote policy solutions to this ongoing public health crisis.
TranspariMED often collaborates with other nonprofits on issues of common interest.
Past and present collaborators include:
-
Collaboration for Research Integrity and Transparency at Yale Law School (CRIT)
TranspariMED is a member of the European Alliance for Responsible R&D and Affordable Medicines.
Set up in March 2017 by transparency campaigner Till Bruckner, TranspariMED has to date received external funding (less than £20,000 total) exclusively from HealthWatch, a UK registered charity that does not accept any funding from the pharmaceutical industry. TranspariMED's work is cross-subsidized through the consulting work of its founder (no pharma clients) and income from a part-time research followship at the QUEST Center of the Berlin School of Health. Any future funding will be promptly and fully disclosed on this website.
TranspariMED supports the AllTrials campaign and encourages other organizations to do the same, but is independent from AllTrials.
All content on this website is the sole responsibility of TranspariMED. Unless explicitly stated otherwise, all TranspariMED outputs are produced without external funding and should not be taken to reflect the views of HealthWatch or other parties. Visitors are welcome to repost and reuse all content on this website as long as they credit TranspariMED as the source and/or link back to this website (Creative Commons BY 3.0 license).
Contact
Email: tillbruckner-AT-gmail-DOT-com
Mobile: +44 (0)7424 617017
Till Bruckner
Warning: Transparency and accountability nerd
-> Founder of TranspariMED
-> Advocacy manager with Transparify
Formerly with AllTrials and Transparency International.
TranspariMED in the media
TranspariMED's work has been cited by national media in the United States, Italy, Germany, Britain, Belgium and Austria, as well as by specialist science and medicine publications worldwide.
Distancing design of phase III trials from drug company influence
BMJ, 20 Jan 2020
UK Heads For Full Trial Transparency
Pink Sheet, 15 Jan 2020
Transparency Advocates Urge Upholding EMA’s Access To Documents Policy
Pink Sheet, 06 Jan 2020
Johna: Ergebnisse klinischer Studien müssen transparent sein
sgp INSIDER (Germany), 03 Jan 2020
"Ergebnisse klinischer Studien müssen transparent sein"
AerzteZeitung (Germany), 03 Jan 2020
Deutsche Universitäten vernachlässigen Veröffentlichung klinischer Studien
Aerzteblatt (Germany), 03 Jan 2020
Unikliniken halten Studienergebnisse zurück
Deutsche Apotheker Zeitung (Germany), 02 Jan 2020
Ergebnisse von Studien kaum veröffentlicht
Deutsche Presseagentur (Germany), 31 Dec 2019
Münchner Unis schlampen bei Veröffentlichung klinischer Studien
Bayerischer Rundfunk (Germany), 31 Dec 2019
Transparimed: Uni Mainz verheimlicht Studienergebnisse
Deutsche Unis halten Studienergebnisse zurück
Spiegel Online (Germany), 31 Dec 2019
Halten Unikliniken Studienergebnisse zurück?
AerzteZeitung (Germany), 31 Dec 2019
Unikliniken halten Studienergebnisse zurück
Pharmazeutische Zeitung (Germany), 31 Dec 2019
Norddeutsche Unis verstecken Studienergebnisse
Unis verheimlichen Studienergebnisse
Tagesschau (Germany), 30 Dec 2019
Vergessene Studien
Sueddeutsche Zeitung (Germany), 30 Dec 2019
Unis veröffentlichen Medizin-Studien nicht vorschriftsgemäß
Deutschlandfunk, 30 Dec 2019
Who Has the Right to See Clinical Trial Data? (Germany)
Applied Clinical Trials, 30 Oct 2019
Columbia University and Clinical Trials: In Thy Light Shall We See the Light
TrialSiteNews, 13 Sept 2019
Columbia needs to do a better job at reporting clinical trial results (op-ed)
Columbia Spectator (US), 12 Sept 2019
U.K. patient groups demand action on trial data nondisclosure as politicians ramp up pressure
Fierce Biotech, 26 August 2019
Les CHU français sont à la traîne sur la transparence des résultats d'essais cliniques
Hospimedia (France), 19 July 2019
Too many drug makers and universities fail to report trial results in Europe
STAT News, 03 July 2019
Transparência em baixa
Revista Pesquisa (Brazil), 07 June 2019
Evropské univerzity ve velké míře ignorují povinnost zveřejňovat výsledky klinických hodnocení
Vesmir (Czech Republic), 03 June 2019
Moins d’un essai clinique universitaire sur cinq respecte les règles de publication
Hemato a la Une (France), 02 June 2019
Clinical trial registry reporting: a transparent solution needed (editorial)
Lancet Oncology, 01 June 2019
The unreported results that are still undermining evidence-based medicine
Cancerworld, 30 May 2019
Fehlende Transparenz bei klinischen Studien
Neues Deutschland (Germany), 09 May 2019
Sperimentazioni cliniche e trasparenza. Quasi tutte le università europee violano le norme Ue
Quotidiano Sanita (Italy), 05 May 2019
Università: c'è scarsa trasparenza sulle sperimentazioni cliniche
Il Sole 24 Ore (Italy), 03 May 2019
Test clinici: il Registro europeo esiste ma gli istituti europei lo ignorano
Il Sole 24 Ore (Italy), 03 May 2019
European universities dismal at reporting results of clinical trials
Nature, 30 April 2019
Clinical trials in Europe: less than a fifth report within 12 months
BMJ, 30 April 2019
EU universities are miserably lax at reporting clinical trial results, analysis suggests
Endpoints News, 30 April 2019
What study findings? Most European universities fail to report clinical trial results
STAT News, 30 April 2019
Europas Medizinunis wenig transparent
ORF (Austria), 30 April 2019
Essais cliniques: le silence coupable des universités
Le Soir (Belgium), 30 April 2019
Universiteiten stellen patiënten bloot aan onnodige risico’s [front page story]
De Morgen (Belgium), 30 April 2019
Universiteiten lappen regels rond klinische proeven aan hun laars: “Patiënten blootgesteld aan onnodige risico’s”
HLN (Belgium), 30 April 2019
Les universités ne publient pas suffisamment les résultats de leurs essais cliniques
Le Specialiste (Belgium), 30 April 2019
'Not a minor misdemeanor': New report finds more than 80% of trials are still unreported
Outsourcing Pharma, 30 April 2019
UK universities report more clinical trial results than EU
TrialSite News, 18 April 2019
UK universities show the way in reporting clinical trial results
BMJ, 17 April 2019
Top Academic Centers Flouting Trial Reporting Requirements, Report Shows
CentreWatch, 01 April 2019
Europe's academics failing to report their clinical trial results [paywalled]
APM Health Europe, 29 March 2019
Some, Not All Results
Genome Web, 29 March 2019
Lack of Transparency in Clinical Trials Results Harms Us All
TrialSite News, 27 March 2019
Top US institutes still aren’t reporting clinical trial results on time
Nature, 26 March 2019
Data suggest US, UK universities fall woefully short on reporting clinical trial results
Endpoints, 26 March 2019
Many leading universities are still failing to report clinical trial results
STAT News, 25 March 2019
EMA implored to improve clinical trial reporting
Outsourcing Pharma, 18 February 2019
Patients at risk as UK universities fail to disclose results of clinical trials
Daily Telegraph, 24 January 2019
Doctors demand to see medical device safety evidence in Europe
ICIJ, 30 November 2018
Doctors demand to see evidence on safety of medical devices approved in Europe
BMJ, 30 Nov 2018
MPs voice concern over clinical trials transparency
PharmaTimes, 31 October 2018
Sponsors ‘still have further to go’ as 50% of trials go unreported
Outsourcing Pharma, 31 October 2018
Call for government to ensure that all clinical trials report their results
Ekklesia, 31 October 2018
Searching for clinical trials: what patients want
Research4Me think tank report, 17 August 2018
Why sponsors need a global view of clinical trial compliance
The Pharma Letter, 17 June 2018
Roundtable: experts share their views on clinical trial transparency
Pharmaceutical Technology, 09 May 2018
Las conclusiones de las investigaciones medicas no son de fiar
Discovery Salud #213, March 2018
Removing the blindfold on medicines pricing
The BMJ, 26 February 2018 [cites 2017 guide for policy makers]
Almost half of all EU medication has no published results, and here’s why
Silicon Republic, 24 January 2018 [cites UK university study results]
Industria Farmacéutica: Como el afán de lucro, los fallos regulatorios y los conflictos de interés causan muerte y despilfarro de recursos públicos
No Gracias, 22 December 2017
Rules on reporting trials must be better enforced, say health integrity groups
BMJ, 13 December 2017
Results of clinical trials ‘missing’ from registries
Times Higher Education (THE), 17 August 2017
Aberdeen University to launch investigation after report uncovers clinical trial failures
The Herald, 21 May 2017